These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 21914792)
1. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family. Hillringhaus L; Yue WW; Rose NR; Ng SS; Gileadi C; Loenarz C; Bello SH; Bray JE; Schofield CJ; Oppermann U J Biol Chem; 2011 Dec; 286(48):41616-41625. PubMed ID: 21914792 [TBL] [Abstract][Full Text] [Related]
2. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Berry WL; Janknecht R Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528 [TBL] [Abstract][Full Text] [Related]
3. Advances in histone demethylase KDM4 as cancer therapeutic targets. Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic and structural studies of KDM-catalysed demethylation of histone 1 isotype 4 at lysine 26. Walport LJ; Hopkinson RJ; Chowdhury R; Zhang Y; Bonnici J; Schiller R; Kawamura A; Schofield CJ FEBS Lett; 2018 Oct; 592(19):3264-3273. PubMed ID: 30156264 [TBL] [Abstract][Full Text] [Related]
5. KDM4 Demethylases: Structure, Function, and Inhibitors. Jiang Y; Liu L; Yang ZQ Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137 [TBL] [Abstract][Full Text] [Related]
6. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. King ON; Li XS; Sakurai M; Kawamura A; Rose NR; Ng SS; Quinn AM; Rai G; Mott BT; Beswick P; Klose RJ; Oppermann U; Jadhav A; Heightman TD; Maloney DJ; Schofield CJ; Simeonov A PLoS One; 2010 Nov; 5(11):e15535. PubMed ID: 21124847 [TBL] [Abstract][Full Text] [Related]
7. Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates. Williams ST; Walport LJ; Hopkinson RJ; Madden SK; Chowdhury R; Schofield CJ; Kawamura A Epigenetics; 2014 Dec; 9(12):1596-603. PubMed ID: 25625844 [TBL] [Abstract][Full Text] [Related]
8. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays. Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747 [TBL] [Abstract][Full Text] [Related]
9. Reader domain specificity and lysine demethylase-4 family function. Su Z; Wang F; Lee JH; Stephens KE; Papazyan R; Voronina E; Krautkramer KA; Raman A; Thorpe JJ; Boersma MD; Kuznetsov VI; Miller MD; Taverna SD; Phillips GN; Denu JM Nat Commun; 2016 Nov; 7():13387. PubMed ID: 27841353 [TBL] [Abstract][Full Text] [Related]
10. Structural basis of a histone H3 lysine 4 demethylase required for stem elongation in rice. Chen Q; Chen X; Wang Q; Zhang F; Lou Z; Zhang Q; Zhou DX PLoS Genet; 2013; 9(1):e1003239. PubMed ID: 23357881 [TBL] [Abstract][Full Text] [Related]
11. Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self-renewal and early development. Pedersen MT; Kooistra SM; Radzisheuskaya A; Laugesen A; Johansen JV; Hayward DG; Nilsson J; Agger K; Helin K EMBO J; 2016 Jul; 35(14):1550-64. PubMed ID: 27266524 [TBL] [Abstract][Full Text] [Related]
12. Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer. Goda S; Isagawa T; Chikaoka Y; Kawamura T; Aburatani H J Biol Chem; 2013 Dec; 288(52):36948-56. PubMed ID: 24214985 [TBL] [Abstract][Full Text] [Related]
13. Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells. Agger K; Miyagi S; Pedersen MT; Kooistra SM; Johansen JV; Helin K Genes Dev; 2016 Jun; 30(11):1278-88. PubMed ID: 27257215 [TBL] [Abstract][Full Text] [Related]
14. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review. Chin YW; Han SY Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267 [TBL] [Abstract][Full Text] [Related]
15. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. Chu CH; Wang LY; Hsu KC; Chen CC; Cheng HH; Wang SM; Wu CM; Chen TJ; Li LT; Liu R; Hung CL; Yang JM; Kung HJ; Wang WC J Med Chem; 2014 Jul; 57(14):5975-85. PubMed ID: 24971742 [TBL] [Abstract][Full Text] [Related]
16. How substrate specificity is imposed on a histone demethylase--lessons from KDM2A. Tsai CL; Shi Y; Tainer JA Genes Dev; 2014 Aug; 28(16):1735-8. PubMed ID: 25128493 [TBL] [Abstract][Full Text] [Related]